Literature DB >> 25017673

Management of nonimmediate hypersensitivity reactions to drugs.

Jean-Claude Roujeau1, Cynthia Haddad2, Maren Paulmann3, Maja Mockenhaupt3.   

Abstract

Nonimmediate hypersensitivity to drugs has a huge diversity of clinical presentations affecting exclusively or predominantly a single organ (most often the skin) or multiple organs. The latter is the rule with drug reaction with eosinophilia and systemic symptoms, and with drug-induced vasculitis. The management includes a dozen successive steps. Finally, the patient should be provided clear information on the suspected cause of the reaction, recommendations for follow-up after severe reactions associated with a risk of sequelae, and clear recommendations for future use of medications. Pharmacovigilance networks should be informed.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Drug reaction with eosinophilia and systemic symptoms (DRESS); Drug-allergic liver injury (DALI); Drug-induced nephritis (DIN); Drug-induced vasculitis; Stevens-Johnson syndrome (SJS); Toxic epidermal necrolysis (TEN)

Mesh:

Year:  2014        PMID: 25017673     DOI: 10.1016/j.iac.2014.04.012

Source DB:  PubMed          Journal:  Immunol Allergy Clin North Am        ISSN: 0889-8561            Impact factor:   3.479


  8 in total

1.  Drug Reaction, Eosinophilia and Systemic Symptoms (DRESS) syndrome secondary to allopurinol with early lymphadenopathy and symptom relapse.

Authors:  Rhiannon Turney; Jordan Peter Skittrall; Joseph Donovan; Daniel Agranoff
Journal:  BMJ Case Rep       Date:  2015-10-05

Review 2.  How I treat hypereosinophilic syndromes.

Authors:  Amy D Klion
Journal:  Blood       Date:  2015-05-11       Impact factor: 22.113

3.  Epidemiology of drug hypersensitivity reactions using 6-year national health insurance claim data from Korea.

Authors:  JaeEun Han; Young-Min Ye; Sukhyang Lee
Journal:  Int J Clin Pharm       Date:  2018-04-02

Review 4.  Non-immediate Cutaneous Reactions to Beta-Lactams: Approach to Diagnosis.

Authors:  Antonino Romano; Rocco Luigi Valluzzi; Cristiano Caruso; Michela Maggioletti; Francesco Gaeta
Journal:  Curr Allergy Asthma Rep       Date:  2017-04       Impact factor: 4.919

Review 5.  Mechanisms of Severe Cutaneous Adverse Reactions: Recent Advances.

Authors:  Teresa Bellón
Journal:  Drug Saf       Date:  2019-08       Impact factor: 5.228

6.  Epidemiology of Severe Cutaneous Adverse Drug Reaction and Its HLA Association among Pediatrics.

Authors:  Hossein Esmaeilzadeh; Shirin Farjadian; Soheila Alyasin; Hamid Nemati; Hesamodin Nabavizadeh; Elmira Esmaeilzadeh
Journal:  Iran J Pharm Res       Date:  2019       Impact factor: 1.696

Review 7.  Morbilliform Eruptions in the Hospitalized Child.

Authors:  Jessica S Haber; Sarah D Cipriano; Vikash S Oza
Journal:  Dermatol Clin       Date:  2022-03-04       Impact factor: 3.478

8.  Severe Toxic Epidermal Necrolysis and Drug Reaction with Eosinophilia and Systemic Symptoms Overlap Syndrome Treated with Benralizumab: A Case Report.

Authors:  Felix K Zeller; Patrick R Bader; Mirjam C Nägeli; Philipp K Buehler; Reto A Schuepbach
Journal:  Case Rep Dermatol       Date:  2022-07-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.